Starna offers new photometric linearity reference sets

Published: 13-May-2010

Suitable for pharmaceutical QA laboratories

Starna Scientific’s near infrared (NIR) traceable photometric linearity reference sets are now available for pharmaceutical QA labs and customer support organisations seeking to qualify their NIR systems. These reference sets offer Operational Qualification (OQ) and Performance Qualification (PQ) of the transmittance scale in the NIR using industry standard protocols.

The sets are based on easy to handle, non-consumable Certified Reference Materials for qualifying the NIR Transmittance scale. The wavelength range covered is 1100 to 2850nm, with a %T (A) range of 1.5 %T (1.82A) to 61%T (0.21A).

Starna, based in Hainault, Essex, UK, has many years of experience gained preparing Visible Neutral Density filter references for ISO 17025 and ISO Guide 34 accreditation and produces references for National Measurement Institutions (NMIs).

See more

You may also like

Research & Development

Quotient Sciences extends partnership for ultra-rare disease treatment

Read more
This collaboration reinforces Quotient Sciences’ commitment to supporting the manufacture of niche and smaller volume commercial products often overlooked by larger CDMOs

Trending Articles

  1. Destination Russia for new NYK Logistics warehouse <p>Logistics specialist NYK is expanding its market presence with the launch of new warehousing operation in Moscow, Russia.</p>
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Procurement as a strategic business enabler How Alkermes unlocked $30m in project cost savings with JAGGAER
  3. Anton Paar expands Litesizer portfolio with cost-effective DLS 301 for routine analysis Designed as a budget-friendly solution for routine analysis, the new instrument provides reliable performance for laboratories working with simpler samples and straightforward quality control workflows
  4. AFYREN obtains FSSC 22000 certification for industrial site The AFYREN NEOXY plant is now certified for the production and processing of biobased monocarboxylic acids and their derivatives for the food and feed industries, a guarantee of trust and performance for customers
  5. NICE approves Opzelura cream as first UK treatment for non-segmental vitiligo Incyte Biosciences UK has secured NICE approval for Opzelura (ruxolitinib) cream, granting eligible NHS patients with non-segmental vitiligo access to the first and only approved therapy in England shown to support facial re-pigmentation

Upcoming event

DCAT Week

23–26 March 2026 | Conference | New York, US See all

You may also like

Research & Development

Quotient Sciences extends partnership for ultra-rare disease treatment

This collaboration reinforces Quotient Sciences’ commitment to supporting the manufacture of niche and smaller volume commercial products often overlooked by larger CDMOs
Research & Development

OSE Immunotherapeutics receives positive IDMC review for Phase III ARTEMIA trial

OSE Immunotherapeutics SA has received a second positive recommendation from the Independent Data Monitoring Committee to continue its Phase III ARTEMIA trial of Tedopi in advanced non-small cell lung cancer
Research & Development

Vilnius University scientists reveal new role for CRISPR-Cas9 in bacterial immunity

The researchers report in Molecular Cell that the CRISPR-Cas9 protein plays a previously unknown role in selecting and integrating viral DNA fragments during bacterial immune memory formation
Research & Development

Lilly’s Orforglipron beats oral semaglutide in Phase III ACHIEVE-3 trial with superior weight loss

Head-to-head data published in The Lancet show Eli Lilly's oral GLP-1 candidate orforglipron delivered significantly greater HbA1c reductions and weight loss than oral semaglutide in adults with type 2 diabetes, supporting global regulatory submissions
Manufacturing

Viatris to cut 10% of its global workforce after Indian plant fire

Viatris has lowered its profit outlook for 2026 after a fire in February shut down a key plant in Nashik, India. Despite this, the company reported stronger-than-expected revenue and announced a restructuring plan
Regulatory

CStone's sugemalimab approved by MHRA for Stage III NSCLC

The MHRA's decision marks the biopharma's second indication approved for the product in the UK, with a global commercial rollout for sugemalimab now actively underway
Manufacturing

GEA opens new technology centre in Germany

The opening of the new technology centre for pharmaceutical freeze-drying systems will strengthen the supplier's position in the growing pharmaceutical applications market
Subscribe now